The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.

Standard

The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. / Lehmann, Elisabeth; El-Tantawy, Walid Hamdy; Ocker, Matthias; Bartenschlager, Ralf; Lohmann, Volker; Hashemolhosseini, Said; Tiegs, Gisa; Sass, Gabriele.

in: HEPATOLOGY, Jahrgang 51, Nr. 2, 2, 2009, S. 398-404.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Lehmann, E, El-Tantawy, WH, Ocker, M, Bartenschlager, R, Lohmann, V, Hashemolhosseini, S, Tiegs, G & Sass, G 2009, 'The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.', HEPATOLOGY, Jg. 51, Nr. 2, 2, S. 398-404. <http://www.ncbi.nlm.nih.gov/pubmed/20044809?dopt=Citation>

APA

Lehmann, E., El-Tantawy, W. H., Ocker, M., Bartenschlager, R., Lohmann, V., Hashemolhosseini, S., Tiegs, G., & Sass, G. (2009). The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. HEPATOLOGY, 51(2), 398-404. [2]. http://www.ncbi.nlm.nih.gov/pubmed/20044809?dopt=Citation

Vancouver

Lehmann E, El-Tantawy WH, Ocker M, Bartenschlager R, Lohmann V, Hashemolhosseini S et al. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. HEPATOLOGY. 2009;51(2):398-404. 2.

Bibtex

@article{3de5b9a58ec14ceeb8a19964e748c756,
title = "The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.",
abstract = "The anti-inflammatory and antiapoptotic heme degrading enzyme heme oxygenase-1 (HO-1) has been shown recently to interfere with replication of hepatitis C virus (HCV). We investigated the effect of HO-1 products carbon monoxide (CO), iron and biliverdin on HCV replication using the replicon cell lines Huh-5-15 and LucUbiNeo-ET, stably expressing HCV proteins NS3 through NS5B. Incubation of these cell lines in the presence of the CO donor methylene chloride transiently reduced HCV replication, whereas an increase of iron in cell culture by administration of FeCl(3) or iron-saturated lactoferrin did not interfere with HCV replication. Likewise, depletion of iron by deferoxamine during induction of HO-1 by cobalt-protoporphyrin IX did not restore HCV replication. The most prominent effect was observed after incubation of replicon cell lines in the presence of biliverdin. Biliverdin seems to interfere with HCV replication-mediated oxidative stress by inducing expression of antiviral interferons, such as interferon alpha2 and alpha17. Conclusion: The antioxidant biliverdin reduces HCV replication in vitro by triggering the antiviral interferon response and might improve HCV therapy in the future. (HEPATOLOGY 2009.).",
author = "Elisabeth Lehmann and El-Tantawy, {Walid Hamdy} and Matthias Ocker and Ralf Bartenschlager and Volker Lohmann and Said Hashemolhosseini and Gisa Tiegs and Gabriele Sass",
year = "2009",
language = "Deutsch",
volume = "51",
pages = "398--404",
journal = "HEPATOLOGY",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

RIS

TY - JOUR

T1 - The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.

AU - Lehmann, Elisabeth

AU - El-Tantawy, Walid Hamdy

AU - Ocker, Matthias

AU - Bartenschlager, Ralf

AU - Lohmann, Volker

AU - Hashemolhosseini, Said

AU - Tiegs, Gisa

AU - Sass, Gabriele

PY - 2009

Y1 - 2009

N2 - The anti-inflammatory and antiapoptotic heme degrading enzyme heme oxygenase-1 (HO-1) has been shown recently to interfere with replication of hepatitis C virus (HCV). We investigated the effect of HO-1 products carbon monoxide (CO), iron and biliverdin on HCV replication using the replicon cell lines Huh-5-15 and LucUbiNeo-ET, stably expressing HCV proteins NS3 through NS5B. Incubation of these cell lines in the presence of the CO donor methylene chloride transiently reduced HCV replication, whereas an increase of iron in cell culture by administration of FeCl(3) or iron-saturated lactoferrin did not interfere with HCV replication. Likewise, depletion of iron by deferoxamine during induction of HO-1 by cobalt-protoporphyrin IX did not restore HCV replication. The most prominent effect was observed after incubation of replicon cell lines in the presence of biliverdin. Biliverdin seems to interfere with HCV replication-mediated oxidative stress by inducing expression of antiviral interferons, such as interferon alpha2 and alpha17. Conclusion: The antioxidant biliverdin reduces HCV replication in vitro by triggering the antiviral interferon response and might improve HCV therapy in the future. (HEPATOLOGY 2009.).

AB - The anti-inflammatory and antiapoptotic heme degrading enzyme heme oxygenase-1 (HO-1) has been shown recently to interfere with replication of hepatitis C virus (HCV). We investigated the effect of HO-1 products carbon monoxide (CO), iron and biliverdin on HCV replication using the replicon cell lines Huh-5-15 and LucUbiNeo-ET, stably expressing HCV proteins NS3 through NS5B. Incubation of these cell lines in the presence of the CO donor methylene chloride transiently reduced HCV replication, whereas an increase of iron in cell culture by administration of FeCl(3) or iron-saturated lactoferrin did not interfere with HCV replication. Likewise, depletion of iron by deferoxamine during induction of HO-1 by cobalt-protoporphyrin IX did not restore HCV replication. The most prominent effect was observed after incubation of replicon cell lines in the presence of biliverdin. Biliverdin seems to interfere with HCV replication-mediated oxidative stress by inducing expression of antiviral interferons, such as interferon alpha2 and alpha17. Conclusion: The antioxidant biliverdin reduces HCV replication in vitro by triggering the antiviral interferon response and might improve HCV therapy in the future. (HEPATOLOGY 2009.).

M3 - SCORING: Zeitschriftenaufsatz

VL - 51

SP - 398

EP - 404

JO - HEPATOLOGY

JF - HEPATOLOGY

SN - 0270-9139

IS - 2

M1 - 2

ER -